Professional Documents
Culture Documents
4. Go to the STIs web site and describe the symptoms of each of the following:
i) Chlamydia
Symptoms for men can include:
ii) Gonorrhea
For men who do experience symptoms, these may include:
sores on the penis, around the testicles, near the anus, or on the thighs or
buttocks
tender lumps in the groin (lymphadenopathy)
Since bacteria cause chlamydia, the disease can often be treated with antibiotics.
Azithromycin is an antibiotic usually prescribed in a single dose, while
doxycycline must be taken twice per day for about one week.
There are other antibiotics that your doctor may prescribe. No matter which
antibiotic you are given, you will need to follow the dosage instructions carefully
to make sure the infection clears up fully. This usually takes two weeks at most,
during which time you will need to refrain from sexual contact.
ii) Gonorrhea
Gonorrhea treatment is complicated by the ability of N. gonorrhoeae to develop
resistance to antimicrobial therapies. Quinolone-resistant N. gonorrhoeae strains
are now widely disseminated throughout the United States and the world. As of
April 2007, quinolones are no longer recommended in the United States for the
treatment of gonorrhea and associated conditions, such as PID ,Consequently,
only one class of antimicrobials, the cephalosporins, is recommended and
available for the treatment of gonorrhea in the United States. The CDC website)
and state health departments can provide the most current information.
iii) Herpes (Genital)
There is no cure for genital herpes, and once a person is infected with genital
herpes, the infection persists throughout the individual's life, with the potential for
recurrent outbreaks. However, there are medications that can reduce the severity
and frequency of outbreaks and treatments to manage the symptoms.
iv)Human Papillomavirus (HPV)
Women (1525 years) were vaccinated at months 0, 1, and 6. Analyses were
done in the according-to-protocol cohort for efficacy (ATP-E; vaccine, n=8093;
control, n=8069), total vaccinated cohort (TVC, included all women receiving at
least one vaccine dose, regardless of their baseline HPV status; represents the
general population, including those who are sexually active; vaccine, n=9319;
control, n=9325), and TVC-naive (no evidence of oncogenic HPV infection at
baseline; represents women before sexual debut; vaccine, n=5822; control,
n=5819). The primary endpoint was to assess vaccine efficacy against cervical
intraepithelial neoplasia 2+ (CIN2+) that was associated with HPV-16 or HPV-18
in women who were seronegative at baseline, and DNA negative at baseline and
month 6 for the corresponding type (ATP-E).
v) Syphilis
Penicillin is used to treat all stages of syphilis. Despite over 60 years of use, the
syphilis bacterium has not yet developed resistance to this original antibiotic. For
primary syphilis, one injection (usually given as half a dose into each buttock) is
enough to permanently cure this disease that once claimed so many lives.
Secondary and latent syphilis are treated the same way. But instead of one
injection there are 3 injections over successive weeks. Most people with
infectious syphilis, especially those in the secondary stage, suffer a reaction
when they're first treated. The symptoms include a sudden fever with headache,
sweating, and possibly a rash. This clears up in less than 24 hours.
Penicillin stops the infectivity within a day or two, and cures the disease in a week
or two. A person should wait until the treatment is finished before engaging in
sex. If the person is allergic to penicillin, another antibiotic can be substituted.
Tertiary syphilis is also treated with penicillin injections. Usually therapy is longer
than just a few doses. Though this doesn't always kill all the hidden bacteria, it
does generally stop further damage. There's no way to repair the organ damage
that's already been done, however.
It is important to keep your follow-up appointments with your doctor. Even though
you may have been treated with antibiotics, treatments have been known to fail.
Your doctor will do some blood tests to make sure that the antibiotics have
worked and that the bacteria have been cleared away.
The best way to avoid these complications is to avoid syphilis by practicing safe
sex. Wearing a condom correctly is a good first step, but standard intercourse is
not the only way to get syphilis. Any mouth-to-genital contact and sometimes
even mouth-to-mouth contact is enough to transmit the disease. To minimize your
risk, limit your number of sexual partners and be careful who they are - ask for a
syphilis (and other STI) test. If you develop syphilis, your sexual partners should
be notified, tested, and possibly treated.
to drug resistance as compared with other drugs, are simple to take (1 pill a
day), and have few side effects so require only limited monitoring.
However, in most people, the treatment does not cure hepatitis B infection, but
only suppresses replication of the virus. Therefore, most people who start
hepatitis B treatment must continue for life.
Treatment using interferon injections may be considered in some people in
certain high-income settings, but its use is less feasible in low-resource
settings due to high cost and significant adverse effects requiring careful
monitoring.
There is still limited access to diagnosis and treatment of hepatitis B in many
resource-constrained settings, and many people are diagnosed only when
they already have advanced liver disease. Liver cancer progresses rapidly,
and since treatment options are limited, the outcome is in general poor. In lowincome settings, most people with liver cancer die within months of diagnosis.
In high-income countries, surgery and chemotherapy can prolong life for up to
a few years. In high-income countries, liver transplantation is sometimes used
in people with cirrhosis, with varying success.
iii) Hep C
Hepatitis C does not always require treatment as the immune response in
some people will clear the infection. When treatment is necessary, the goal of
hepatitis C treatment is cure. The cure rate depends on several factors
including the strain of the virus and the type of treatment given. Careful
screening is necessary before starting the treatment to determine the most
appropriate approach for the patient.
The current standard treatment for hepatitis C is combination antiviral therapy
with interferon and ribavirin, which are effective against all the genotypes of
hepatitis viruses (pan-genotypic). Unfortunately, interferon is not widely
available globally and it is poorly tolerated in some patients. This means that
management of the treatment is complex, and many patients do not finish their
treatment. Despite these limitations, interferon and ribavirin treatment can be
life-saving.
Scientific advances have led to the development of new antiviral drugs for
hepatitis C, which are much more effective, safer and better-tolerated than
existing therapies. These therapies, known as oral directly acting antiviral
agent (DAAs) therapies simplify hepatitis C treatment by significantly
decreasing monitoring requirements and by increasing cure rates. Although
the production cost of DAAs is low, the initial prices set by companies are very
high and likely to make access to these drugs difficult even in high-income
countries.
Much needs to be done to ensure that these advances lead to greater access
to treatment globally.
l0. What are the consequences of each of the three types of hepatitis?
Hep A
Hepatitis A is a viral liver disease that can cause mild to severe illness.
Globally, there are an estimated 1.4 million cases of hepatitis A every
year.
The hepatitis A virus is transmitted through ingestion of contaminated
food and water, or through direct contact with an infectious person.
Hepatitis A is associated with a lack of safe water and poor sanitation.
Epidemics can be explosive and cause significant economic losses.
Improved sanitation and the hepatitis A vaccine are the most effective
ways to combat the disease.
Hep B
Hepatitis B is a viral infection that attacks the liver and can cause both
acute and chronic disease.
The virus is transmitted through contact with the blood or other body
fluids of an infected person.
An estimated 240 million people are chronically infected with hepatitis B
(defined as hepatitis B surface antigen positive for at least 6 months).
Approximately 780 000 persons die each year from hepatitis B infection
-- 650 000 from cirrhosis and liver cancer due to chronic hepatitis B
infection and another 130 000 from acute hepatitis B.1
Hepatitis B is an important occupational hazard for health workers.
However, it can be prevented by currently available safe and effective
vaccine.
Hep C
Hepatitis C is a liver disease caused by the hepatitis C virus: the virus
can cause both acute and chronic hepatitis infection, ranging in severity
from a mild illness lasting a few weeks to a serious, lifelong illness.
The hepatitis C virus is a bloodborne virus and the most common
modes of infection are through unsafe injection practices; inadequate